202 related articles for article (PubMed ID: 28388234)
1. Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules.
Im SW; Pravinsagar P; Im SR; Jang YJ
Immunol Invest; 2017 Jul; 46(5):500-517. PubMed ID: 28388234
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cells.
Fang J; Wang H; Xi W; Cheng G; Wang S; Su S; Zhang S; Deng Y; Song Z; Xu A; Liu B; Cao J; Wang Z
Tumour Biol; 2015 Jul; 36(7):5209-14. PubMed ID: 25669170
[TBL] [Abstract][Full Text] [Related]
3. Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells.
Im SR; Im SW; Chung HY; Pravinsagar P; Jang YJ
Mol Immunol; 2015 Oct; 67(2 Pt B):377-87. PubMed ID: 26189065
[TBL] [Abstract][Full Text] [Related]
4. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
Li H; Zheng X; Koren V; Vashist YK; Tsui TY
Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
[TBL] [Abstract][Full Text] [Related]
6. Engineering of a tumor cell-specific, cytosol-penetrating antibody with high endosomal escape efficacy.
Kim JS; Park JY; Shin SM; Park SW; Jun SY; Hong JS; Choi DK; Kim YS
Biochem Biophys Res Commun; 2018 Sep; 503(4):2510-2516. PubMed ID: 30208519
[TBL] [Abstract][Full Text] [Related]
7. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine.
Lee SA; Kim BR; Kim BK; Kim DW; Shon WJ; Lee NR; Inn KS; Kim BJ
Biomaterials; 2013 Oct; 34(30):7495-505. PubMed ID: 23827187
[TBL] [Abstract][Full Text] [Related]
9. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the internalization mechanism of WRAP:siRNA nanoparticles.
Deshayes S; Konate K; Dussot M; Chavey B; Vaissière A; Van TNN; Aldrian G; Padari K; Pooga M; Vivès E; Boisguérin P
Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183252. PubMed ID: 32135145
[TBL] [Abstract][Full Text] [Related]
11. PTD-DRBD siRNA delivery.
Palm-Apergi C; Eguchi A; Dowdy SF
Methods Mol Biol; 2011; 683():339-47. PubMed ID: 21053141
[TBL] [Abstract][Full Text] [Related]
12. Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells.
Alekseev OM; Richardson RT; Tsuruta JK; O'Rand MG
Reprod Biol Endocrinol; 2011 Apr; 9():50. PubMed ID: 21496299
[TBL] [Abstract][Full Text] [Related]
13. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
[TBL] [Abstract][Full Text] [Related]
14. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
16. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
17. An autoantibody is modified for use as a delivery system to target the cell nucleus: therapeutic implications.
Weisbart RH; Stempniak M; Harris S; Zack DJ; Ferreri K
J Autoimmun; 1998 Oct; 11(5):539-46. PubMed ID: 9802941
[TBL] [Abstract][Full Text] [Related]
18. DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.
Zannikou M; Bellou S; Eliades P; Hatzioannou A; Mantzaris MD; Carayanniotis G; Avrameas S; Lymberi P
Immunology; 2016 Jan; 147(1):73-81. PubMed ID: 26447818
[TBL] [Abstract][Full Text] [Related]
19. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
